Prices delayed by at least 15 minutes | Print
Chimerix (CMRX)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
Address
2505 Meridian Parkway
Suite 340
Durham
NC
USA
27713
Telephone
+1 919 806-1074
Forecast key dates
| Name | Key Date |
|---|---|
| Chimerix Inc First Quarter Earnings Conference Call for 2025 | 2025-05-01T08:30:00 |
| Chimerix Inc First Quarter Earnings Results for 2025 | 2025-05-01T00:00:00 |
| Chimerix Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-02-28T08:30:00 |
| Chimerix Inc Fourth Quarter Earnings Results for 2024 | 2025-02-28T00:00:00 |
| Chimerix Inc Annual Report for 2024 | 2025-02-28T00:00:00 |
| Chimerix Inc Third Quarter Earnings Conference Call for 2024 | 2024-11-01T08:30:00 |
| Chimerix Inc Third Quarter Earnings Results for 2024 | 2024-11-01T00:00:00 |
| Chimerix Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-02T08:30:00 |
| Chimerix Inc Second Quarter Earnings Results for 2024 | 2024-08-02T00:00:00 |
| Chimerix Inc Annual General Meeting for 2024 | 2024-06-07T08:00:00 |
| Chimerix Inc First Quarter Earnings Conference Call for 2024 | 2024-05-01T08:30:00 |
| Chimerix Inc First Quarter Earnings Result for 2024 | 2024-05-01T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Chimerix Inc First Quarter Earnings Conference Call for 2024 | 2024-05-01T08:30:00 |
| Chimerix Inc First Quarter Earnings Result for 2024 | 2024-05-01T00:00:00 |
| TD Cowen 44th Annual Health Care Conference | 2024-03-05T12:50:00 |
| Chimerix Inc Fourth Quarter Earnings Conference Call for 2023 | 2024-02-29T08:30:00 |
| Chimerix Inc Fourth Quarter Earnings Result for 2023 | 2024-02-29T00:00:00 |
| Chimerix Inc Annual Report for 2023 | 2024-02-29T00:00:00 |
| Chimerix Inc Third Quarter Earnings Conference Call for 2023 | 2023-11-02T08:30:00 |
| Chimerix Inc Third Quarter Earnings Result for 2023 | 2023-11-02T00:00:00 |
| Chimerix Inc Second Quarter Earnings Conference Call for 2023 | 2023-08-03T08:30:00 |
| Chimerix Inc Second Quarter Earnings Result for 2023 | 2023-08-03T00:00:00 |
| Chimerix Inc Annual General Meeting for 2023 | 2023-06-09T08:00:00 |
| Chimerix Inc First Quarter Earnings Conference Call for 2023 | 2023-05-04T08:30:00 |
| Chimerix Inc First Quarter Earnings Result for 2023 | 2023-05-04T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.